CRMP5 has been the last member of the family to be identified in the mouse [7] and rat [8], but also in man where this protein is the main target of auto-antibodies developed by patients with paraneoplasic neurological diseases [9], [10]. The gene discussed is DPYSL5; the disease is nervous system disorder.